| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1922476 | Parkinsonism & Related Disorders | 2009 | 4 Pages |
Abstract
Levodopa serves as the gold standard of anti-parkinsonian therapy and nearly every patient with Parkinson's disease eventually receives this drug. To improve upon levodopa therapy, several forms of treatment have been devised to augment its actions, and new delivery systems are under development. This new research offers promise for improving outcomes with this highly effective therapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Peter A. LeWitt,